An outside vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) today voted to recommend the single-dose Johnson & Johnson COVID-19 vaccine after discussing study findings and policy and clinical considerations. Their interim recommendation, moving a third vaccine option just a step away from distribution, comes on the heels of the Food and Drug Administration (FDA) emergency use authorization (EUA) announcement last night, accepting its advisory group’s recommendation.

 

MarsBars/iStock

Read more CIDRAP…